Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Incyte Corporation
Related studies linked through entity extraction aliases.
Efficacy and Safety of Pemigatinib in Participants With Solid Tumors With FGFR Mutations or Translocations (FIGHT-208)
- Status
- TERMINATED
- Phase
- PHASE2
Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205)
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of Itacitinib in Participants With Bronchiolitis Obliterans Syndrome Following Lung Transplantation
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE1
INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Expanded Access of Pemigatinib to Treat a Single Patient With Metastatic Pancreatic Cancer
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Expanded Access Use of INCB052793 to Treat a Single Patient With Myelofibrosis
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
- Status
- COMPLETED
- Phase
- PHASE3
Expanded Access Use of INCB054329 to Treat a Single Patient With Metastatic Renal Cell Carcinoma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)
- Status
- TERMINATED
- Phase
- PHASE3
INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and Epacadostat
- Status
- TERMINATED
- Phase
- PHASE2